LUMICKS

📍 Amsterdam, Netherlands🗓 Founded 2014👥 197 employees💰 Last funded Apr 2021
Biotechnology Research🌐 lumicks.com
Website LinkedIn
LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in LUMICKS?
LUMICKS has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did LUMICKS last raise funding?
The most recent investment in LUMICKS recorded on gritt.io was in April 2021.
When was LUMICKS founded?
LUMICKS was founded in 2014.
What industry is LUMICKS in?
LUMICKS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is LUMICKS based?
LUMICKS is headquartered in Amsterdam, Netherlands.